Literature DB >> 9597379

Skin lesions in diabetes mellitus: prevalence and clinical correlations.

G Romano1, G Moretti, A Di Benedetto, C Giofrè, E Di Cesare, G Russo, L Califano, D Cucinotta.   

Abstract

With the aim to assess the prevalence and the main clinical correlations of skin lesions in diabetes mellitus, 457 diabetic subjects consecutively attending an outpatient clinic underwent a dermatological examination. Neurovascular foot lesions were excluded. Thirty-five of 64 IDDM patients (54%) had skin alterations mainly consisting of vitiligo (9% of all patients), psoriasis (9%) and eczema (8%). The most frequent skin lesions observed in 240/393 NIDDM subjects (61%) were represented by infections (20% of all patients) and diabetic dermopathy (12.5%), while other lesions were not common. NIDDM patients with skin infections had a worse metabolic control, and those with diabetic dermopathy had a greater prevalence of neuropathy and large vessel disease than patients without skin lesions. These data show that the prevalence of skin diseases in a large, unselected diabetic population is higher than expected and indicate that, in most cases, a careful dermatological examination and a better metabolic control are needed in order to improve quality of life in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597379     DOI: 10.1016/s0168-8227(97)00119-8

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  21 in total

Review 1.  [Cutaneous manifestations of metabolic syndrome].

Authors:  G Holzer; B Straßegger; B Volc-Platzer
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

2.  Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.

Authors:  Gökhan Okan; Adile Merve Baki; Eda Yorulmaz; Semra Doğru-Abbasoğlu; Pervin Vural
Journal:  J Clin Lab Anal       Date:  2015-04-13       Impact factor: 2.352

Review 3.  Complications associated with new-onset diabetes after kidney transplantation.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  Nat Rev Nephrol       Date:  2011-11-15       Impact factor: 28.314

4.  The diabetic foot and leg: combined He-Ne and infrared low-intensity lasers improve skin blood perfusion and prevent potential complications. A prospective study on 30 Egyptian patients.

Authors:  Gamal M Saied; Ragia M Kamel; Awatif M Labib; Mohamed T Said; Abir Z Mohamed
Journal:  Lasers Med Sci       Date:  2011-04-01       Impact factor: 3.161

Review 5.  Dermatologic conditions associated with diabetes.

Authors:  Karen Nern
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

6.  Pattern of cutaneous manifestations in diabetes mellitus.

Authors:  Abhishek Goyal; Sujeet Raina; Satinder S Kaushal; Vikram Mahajan; Nand Lal Sharma
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

7.  An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care Hospital of Eastern India.

Authors:  Nandini Chatterjee; Chandan Chattopadhyay; Nilanjan Sengupta; Chanchal Das; Nilendu Sarma; Salil K Pal
Journal:  Indian J Endocrinol Metab       Date:  2014-03

Review 8.  Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis.

Authors:  Nader Salari; Amin Hosseinian-Far; Melika Hosseinian-Far; Hossein Kavoussi; Rostam Jalali; Aliakbar Vaisi-Raygani; Shabnam Rasoulpoor; Shna Rasoulpoor; Masoud Mohammadi; Shervin Shabani
Journal:  J Diabetes Metab Disord       Date:  2020-09-09

9.  The association between Solar Lentigines and Type-2 Diabetes.

Authors:  Bobak Moazzami; Niloofar Razavi; Mansour Babaei; Motahareh Haghparast; Mohammad Ali Bayani
Journal:  Caspian J Intern Med       Date:  2017

10.  The skin landscape in diabetes mellitus. Focus on dermocosmetic management.

Authors:  Gérald E Piérard; Sophie Seité; Trinh Hermanns-Lê; Philippe Delvenne; André Scheen; Claudine Piérard-Franchimont
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.